Sichuan Huiyu Pharmaceutical Co., Ltd.
As of 20 November 2026, for the company name Sichuan Huiyu Pharmaceutical Co., Ltd. as recorded, 4 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 81 records, across 43 drug names; since 24 August 2026, the records list Marketing application approved: 3 applications; the chemical-drug catalogue lists 53 active records with this name as holder; 22 active API registrations list this name as first registered company; 42 further acceptance records name it after the first applicant.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/20.
Drug filings
81 acceptance records as first applicant, grouped into 43 source drug names. Source data as of 2026/11/20.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Amphotericin B Liposome for Injection 1 records · Latest accepted 2026/05/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601023 | Generic | 2026/05/01 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Zoledronic Acid Injection 2 records · Latest accepted 2025/12/06
Supplement · 1Generic · 1
Zoledronic Acid Concentrated Solution for Injection 2 records · Latest accepted 2025/10/28
Supplement · 1Generic · 1
Docetaxel Injection 6 records · Latest accepted 2025/07/30
Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501504 | Supplement | 2025/07/30 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2501503 | Supplement | 2025/07/30 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2101712 | Supplement | 2021/08/23 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2101711 | Supplement | 2021/08/23 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2101046 | Supplement | 2021/03/23 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2101045 | Supplement | 2021/03/23 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Iron Sucrose Injection 1 records · Latest accepted 2025/07/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502379 | Generic | 2025/07/05 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
HY-2003 · No verified English name 2 records · Latest accepted 2025/02/07
Supplement · 1New drug · 1
Cytarabine for Injection 2 records · Latest accepted 2025/01/23
Supplement · 2
醋酸兰瑞肽缓释注射液(预充式) · No verified English name 3 records · Latest accepted 2024/12/12
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404311 | Generic | 2024/12/12 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2404310 | Generic | 2024/12/12 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2404309 | Generic | 2024/12/12 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Oxaliplatin Injection 2 records · Latest accepted 2024/10/18
Supplement · 2
Paclitaxel Injection 1 records · Latest accepted 2024/10/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401615 | Supplement | 2024/10/10 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Pemetrexed Disodium for Injection 4 records · Latest accepted 2024/09/21
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401537 | Supplement | 2024/09/21 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2401536 | Supplement | 2024/09/21 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2101144 | Supplement | 2021/04/16 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2101143 | Supplement | 2021/04/16 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Nicardipine Hydrochloride Injection 1 records · Latest accepted 2024/07/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402043 | Generic | 2024/07/06 | Sichuan Huiyu Pharmaceutical Co., Ltd.; Chengdu Tian Tai Shan Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Etoposide Injection 2 records · Latest accepted 2024/05/09
Generic · 2
Cimetidine Injection 1 records · Latest accepted 2024/04/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401262 | Generic | 2024/04/26 | Sichuan Huiyu Pharmaceutical Co., Ltd.; Chengdu Tian Tai Shan Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Ferric Carboxymaltose Injection 2 records · Latest accepted 2024/04/25
Generic · 2
Melphalan Hydrochloride For Injection 1 records · Latest accepted 2023/12/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303325 | Generic | 2023/12/01 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Fulvestrant Injection 2 records · Latest accepted 2023/11/28
Supplement · 1Generic · 1
Calcium Folinate Injection 2 records · Latest accepted 2023/09/14
Generic · 2
Carfilzomib For Injection 3 records · Latest accepted 2023/05/24
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301412 | Generic | 2023/05/24 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2301411 | Generic | 2023/05/24 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2301410 | Generic | 2023/05/24 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Methocarbamol Injection 1 records · Latest accepted 2023/05/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301383 | Generic | 2023/05/23 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Methotrexate Injection 3 records · Latest accepted 2023/04/21
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301117 | Generic | 2023/04/21 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2300254 | Generic | 2023/01/31 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2300002 | Generic | 2023/01/04 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Cyclophosphamide for Injection 2 records · Latest accepted 2023/02/04
Generic · 2
Nimodipine Injection 1 records · Latest accepted 2023/02/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300281 | Generic | 2023/02/01 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Levofolinate Calcium for Injection 2 records · Latest accepted 2023/01/09
Generic · 2
Acetylcysteine Injection 1 records · Latest accepted 2022/10/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201814 | Generic | 2022/10/25 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Cladribine Injection 1 records · Latest accepted 2022/10/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201733 | Generic | 2022/10/14 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Decitabine For Injection 2 records · Latest accepted 2022/10/13
Generic · 2
Methotrexate For Injection 1 records · Latest accepted 2022/10/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250624 | Supplement | 2022/10/10 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Irinotecan Hydrochloride Injection 1 records · Latest accepted 2022/09/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201783 | Supplement | 2022/09/29 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Cytarabine Injection 2 records · Latest accepted 2022/09/20
Generic · 2
Teicoplanin for Injection 2 records · Latest accepted 2022/09/17
Generic · 2
Morinidazole and Sodium Chloride Injection 1 records · Latest accepted 2022/09/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201499 | Generic | 2022/09/10 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Roxatidine Acetate Hydrochloride For Injection 1 records · Latest accepted 2022/07/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201160 | Generic | 2022/07/28 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Sodium Thiosulfate Injection 3 records · Latest accepted 2022/06/28
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200963 | Generic | 2022/06/28 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2200503 | Generic | 2022/03/30 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2200502 | Generic | 2022/03/30 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Octreotide Acetate Injection 1 records · Latest accepted 2022/06/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200889 | Generic | 2022/06/16 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Epirubicin Hydrochloride for Injection 1 records · Latest accepted 2021/12/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2102162 | Generic | 2021/12/09 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Azacitidine For Injection 2 records · Latest accepted 2021/12/09
Supplement · 2
Fluorouracil Injection 2 records · Latest accepted 2021/11/24
Generic · 2
Gemcitabine Hydrochloride for Injection 2 records · Latest accepted 2021/09/15
Generic · 2
Milrinone Injection 2 records · Latest accepted 2021/09/13
Generic · 2
丁苯酞注射液 · No verified English name 1 records · Latest accepted 2021/08/18
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2101404 | New drug | 2021/08/18 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Cisatracurium Besylate Injection 2 records · Latest accepted 2021/07/09
Generic · 2
Sodium Valproate Concentrated Solution for Injection 4 records · Latest accepted 2021/04/23
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101086 | Generic | 2021/04/23 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2101023 | Generic | 2021/03/18 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2101022 | Generic | 2021/03/18 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2101021 | Generic | 2021/03/18 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Changes in the last 90 days
3 events from 2026/08/24 to 2026/11/21. CDE data as of 2026/11/20; NMPA data as of 2026/11/20.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Marketing application approved: 3 applications
- 2026/11/03Marketing application approved
醋酸兰瑞肽缓释注射液(预充式) · No verified English name
CYHS2404311 · 国药准字H20266504
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Date added to this site: 2026/11/06
View source · Table row 12 ↗ - 2026/11/03Marketing application approved
醋酸兰瑞肽缓释注射液(预充式) · No verified English name
CYHS2404310 · 国药准字H20266503
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Date added to this site: 2026/11/06
View source · Table row 11 ↗ - 2026/11/03Marketing application approved
醋酸兰瑞肽缓释注射液(预充式) · No verified English name
CYHS2404309 · 国药准字H20266502
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Date added to this site: 2026/11/06
View source · Table row 10 ↗
Under review
4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/20.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Amphotericin B Liposome for Injection | CYHS2601023 | Generic | 2026/05/01 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Iron Sucrose Injection | CYHS2502379 | Generic | 2025/07/05 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ferric Carboxymaltose Injection | CYHS2401239 | Generic | 2024/04/25 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ferric Carboxymaltose Injection | CYHS2401237 | Generic | 2024/04/25 | Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
53 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/20. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | NMPA approval no. | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Carfilzomib For Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20263540 | 2026/03/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carfilzomib For Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20263538 | 2026/03/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carfilzomib For Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20263539 | 2026/03/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cimetidine Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Chengdu Tian Tai Shan Pharmaceutical Co., Ltd. romanized | 国药准字H20256290 | 2025/12/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nicardipine Hydrochloride Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Chengdu Tian Tai Shan Pharmaceutical Co., Ltd. romanized | 国药准字H20256211 | 2025/12/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Melphalan Hydrochloride For Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20253620 | 2025/03/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Calcium Folinate Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20253154 | 2025/01/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Morinidazole and Sodium Chloride Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20249416 | 2024/11/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Teicoplanin for Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20249206 | 2024/10/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Teicoplanin for Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20249205 | 2024/10/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Acetylcysteine Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20249093 | 2024/10/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Methotrexate Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20244883 | 2024/09/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cyclophosphamide for Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20244714 | 2024/08/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cyclophosphamide for Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20244715 | 2024/08/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levofolinate Calcium for Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20244545 | 2024/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levofolinate Calcium for Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20244546 | 2024/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Methotrexate Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20244577 | 2024/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Decitabine For Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20244252 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Decitabine For Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20244253 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Octreotide Acetate Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20244015 | 2024/06/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Roxatidine Acetate Hydrochloride For Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20243662 | 2024/05/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cladribine Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20243553 | 2024/04/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Methotrexate Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20243492 | 2024/04/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gemcitabine Hydrochloride for Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20243258 | 2024/02/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gemcitabine Hydrochloride for Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20243259 | 2024/02/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Methotrexate For Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20043647 | 2023/11/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cisatracurium Besylate Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20233949 | 2023/07/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cisatracurium Besylate Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20233950 | 2023/07/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Zoledronic Acid Concentrated Solution for Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20233946 | 2023/07/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Zoledronic Acid Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20233910 | 2023/07/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Thiosulfate Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20233615 | 2023/05/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Thiosulfate Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20233614 | 2023/05/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Milrinone Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20233501 | 2023/04/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Milrinone Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20233500 | 2023/04/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fluorouracil Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20233517 | 2023/04/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fluorouracil Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20233518 | 2023/04/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Epirubicin Hydrochloride for Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20233195 | 2023/02/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Valproate Concentrated Solution for Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20223478 | 2022/07/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Valproate Concentrated Solution for Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20223268 | 2022/04/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Valproate Concentrated Solution for Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20223267 | 2022/04/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levetiracetam Concentrated Solution for Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20223181 | 2022/03/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bortezomib For Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20223031 | 2022/01/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bortezomib For Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20223030 | 2022/01/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Palonosetron Hydrochloride Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20213850 | 2021/11/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Irinotecan Hydrochloride Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20213206 | 2021/03/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Irinotecan Hydrochloride Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20213205 | 2021/03/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bendamustine Hydrochloride For Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20213144 | 2021/02/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bendamustine Hydrochloride For Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20213145 | 2021/02/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oxaliplatin Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20213061 | 2021/01/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oxaliplatin Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20213060 | 2021/01/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Paclitaxel Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20203702 | 2020/12/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Paclitaxel Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20203703 | 2020/12/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Plerixafor Injection | Sichuan Huiyu Pharmaceutical Co., Ltd. | Sichuan Huiyu Pharmaceutical Co., Ltd. | 国药准字H20223433 | 2022/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
22 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/20.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 环磷酰胺 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20260000091 | I | 2026/02/27 | CDE ↗ |
| 异甘草酸镁 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20260000143 | I | 2026/02/26 | CDE ↗ |
| 布立西坦 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20250001175 | I | 2025/11/13 | CDE ↗ |
| 马来酸麦角新碱 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20250000564 | I | 2025/06/24 | CDE ↗ |
| 枸橼酸伊沙佐米 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20250000534 | A | 2026/10/21 | CDE ↗ |
| 蔗糖铁 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20250000467 | I | 2025/05/21 | CDE ↗ |
| 盐酸尼卡地平 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20240000490 | A | 2025/12/14 | CDE ↗ |
| 羧基麦芽糖铁 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20240000291 | I | 2024/04/01 | CDE ↗ |
| 醋酸兰瑞肽 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20240000207 | A | 2025/08/22 | CDE ↗ |
| 醋酸戈舍瑞林 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20230000756 | A | 2025/04/07 | CDE ↗ |
| 亚叶酸钙 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20230000564 | A | 2025/01/23 | CDE ↗ |
| 盐酸美法仑 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20230000509 | A | 2025/03/16 | CDE ↗ |
| 卡非佐米 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20230000105 | A | 2026/03/19 | CDE ↗ |
| 依托泊苷 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20220001332 | A | 2026/02/13 | CDE ↗ |
| 硼替佐米 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20220001289 | A | 2023/12/27 | CDE ↗ |
| 左亚叶酸钙 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20220001009 | A | 2024/08/10 | CDE ↗ |
| 克拉屈滨 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20220000821 | A | 2025/08/30 | CDE ↗ |
| 氨磷汀 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20220000778 | A | 2026/01/28 | CDE ↗ |
| 甲氨蝶呤 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20220000758 | A | 2026/01/17 | CDE ↗ |
| 塞替派 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20220000484 | A | 2025/04/03 | CDE ↗ |
| 吗啉硝唑 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20220000527 | A | 2026/01/28 | CDE ↗ |
| 盐酸罗沙替丁醋酸酯 · No verified English name | Sichuan Huiyu Pharmaceutical Co., Ltd. | Y20220000475 | A | 2025/04/03 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
42 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/20.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Colistimethate Sodium for Injection | CYHS2602859 | Generic | 2026/11/19 | Tianjin Chase Sun Pharmaceutical Co.,Ltd; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Nitroglycerin Injection | CYHB2601818 | Supplement | 2026/09/28 | Chengdu Rui Er Pharmaceuticals Technology Co., Ltd. romanized; E Mei Shan Tong Hui Pharmaceutical Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Nitroglycerin Injection | CYHB2601817 | Supplement | 2026/09/28 | Chengdu Rui Er Pharmaceuticals Technology Co., Ltd. romanized; E Mei Shan Tong Hui Pharmaceutical Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| 美洛昔康注射液(II) · No verified English name | CYHB2601650 | Supplement | 2026/08/28 | Nanjing Qing Pu Bio Technology Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd.; Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd | CDE ↗ |
| Raltitrexed for Injection | CYHS2602095 | Generic | 2026/08/24 | Sichuan Shuang Tong Medical Technology Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用泼尼松龙琥珀酸钠 · No verified English name | CYHS2601810 | Generic | 2026/07/28 | Nanjing En Tai Pharmaceuticals Technology Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用泼尼松龙琥珀酸钠 · No verified English name | CYHS2601809 | Generic | 2026/07/28 | Nanjing En Tai Pharmaceuticals Technology Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用泼尼松龙琥珀酸钠 · No verified English name | CYHS2601808 | Generic | 2026/07/28 | Nanjing En Tai Pharmaceuticals Technology Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| HY-2003 · No verified English name | CXHB2600217 | Supplement | 2026/07/08 | 四川汇宇海玥医药科技有限公司; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Methylprednisolone Sodium Succinate for injection | CYHS2601473 | Generic | 2026/06/23 | Wuhan Ren Fu Pharma Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Methylprednisolone Sodium Succinate for injection | CYHS2601472 | Generic | 2026/06/23 | Wuhan Ren Fu Pharma Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Hydrocortisone Sodium Succinate for Injection | CYHS2601434 | Generic | 2026/06/17 | Wuhan Ren Fu Pharma Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| 美洛昔康注射液(II) · No verified English name | CYHB2600673 | Supplement | 2026/04/03 | Nanjing Qing Pu Bio Technology Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd.; Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd | CDE ↗ |
| Finasteride Tablets | CYHS2600235 | Generic | 2026/01/21 | Shanxi Zhen Dong An Xin Biopharmaceutical Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Finasteride Tablets | CYHS2600234 | Generic | 2026/01/21 | Shanxi Zhen Dong An Xin Biopharmaceutical Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用QP-6211 · No verified English name | CXHS2500166 | New drug | 2025/12/31 | Nanjing Qing Pu Bio Technology Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Gadoteric Acid Meglumine Salt Injection | CYHS2503123 | Generic | 2025/08/26 | Chengdu Ke Lai Meng Pharmaceuticals Technology Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Methotrexate Injection | CYHS2502469 | Generic | 2025/07/11 | 四川汇宇海玥医药科技有限公司; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Methotrexate Injection | CYHS2502468 | Generic | 2025/07/11 | 四川汇宇海玥医药科技有限公司; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ioversol Injection | CYHS2501798 | Generic | 2025/05/17 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ioversol Injection | CYHS2501797 | Generic | 2025/05/17 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Voriconazole for Injection | CYHS2501303 | Generic | 2025/04/07 | Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Hydrocortisone Sodium Succinate for Injection | CYHS2404176 | Generic | 2024/12/04 | Chengdu Mi Zi Biopharmaceuticals Technology Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Hydrocortisone Sodium Succinate for Injection | CYHS2404175 | Generic | 2024/12/04 | Chengdu Mi Zi Biopharmaceuticals Technology Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Nitroglycerin Injection | CYHS2402294 | Generic | 2024/07/20 | Chengdu Rui Er Pharmaceuticals Technology Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Nitroglycerin Injection | CYHS2402293 | Generic | 2024/07/20 | Chengdu Rui Er Pharmaceuticals Technology Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Methocarbamol Injection | CYHB2400434 | Supplement | 2024/03/28 | 四川汇宇海玥医药科技有限公司; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| HYP-2090PTSA胶囊 · No verified English name | CXHB2400057 | Supplement | 2024/02/27 | 四川汇宇海玥医药科技有限公司; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| HYP-2090PTSA胶囊 · No verified English name | CXHB2400056 | Supplement | 2024/02/27 | 四川汇宇海玥医药科技有限公司; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Acetylcysteine Injection | CYHS2400245 | Generic | 2024/01/17 | Sichuan Shang Shan Liu Jing Pharmaceuticals Technology Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Polymyxin B sulfate for Injection | CYHS2302839 | Generic | 2023/10/21 | 四川汇宇海玥医药科技有限公司; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Thiotepa for Injection | CYHS2302164 | Generic | 2023/08/17 | 四川汇宇海玥医药科技有限公司; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Thiotepa for Injection | CYHS2302163 | Generic | 2023/08/17 | 四川汇宇海玥医药科技有限公司; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cytarabine for Injection | CYHS2301707 | Generic | 2023/06/28 | Sichuan Shang Shan Liu Jing Pharmaceuticals Technology Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cytarabine for Injection | CYHS2301706 | Generic | 2023/06/28 | Sichuan Shang Shan Liu Jing Pharmaceuticals Technology Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Nimodipine Injection | CYHB2300790 | Supplement | 2023/04/18 | 四川汇宇海玥医药科技有限公司; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Thiotepa for Injection | CYHS2300983 | Generic | 2023/04/05 | 四川汇宇海玥医药科技有限公司; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Thiotepa for Injection | CYHS2300982 | Generic | 2023/04/05 | 四川汇宇海玥医药科技有限公司; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Amifostine For Injection | CYHS2300477 | Generic | 2023/02/11 | 四川汇宇海玥医药科技有限公司; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Sodium Valproate Concentrated Solution for Injection | CYHB2201947 | Supplement | 2022/10/22 | Chengdu Giantech Hi-technology Development Co., Ltd.; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Irinotecan Hydrochloride Injection | CYHB2200116 | Supplement | 2022/01/14 | Chengdu Giantech Hi-technology Development Co., Ltd.; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ibuprofen Lysine Injection | CYHS2101904 | Generic | 2021/10/21 | Sichuan Wei Ao Pharmaceutical Co., Ltd. romanized; Sichuan Huiyu Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/20
- Chemical-drug catalogue
- Last successful update: 2026/11/20
- API registrations
- Last successful update: 2026/11/20
- NMPA drug delivery notices
- Last successful update: 2026/11/20
Loaded notices dated 2026-11-06 to 2026-11-20; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.